Add Yahoo as a preferred source to see more of our stories on Google. Invivyd had also attempted to attain regulatory approval for pemivibart.Credit: Design_Cells via Shutterstock. (Design_Cells via ...

Completed clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events and no viral rebounds ...

The updated NCCN Guidelines now include the recommendation for monoclonal antibodies for pre-exposure prophylaxis against COVID-19, highlighting the significance of Invivyd's products in cancer care.

Interim data captured from a phase 3 trial suggest pemivibart may be effective prophylaxis against COVID-19 infection for high-risk patients with significant immunocompromising conditions who continue ...

Emmy Award-winning journalist Paula Ebben co-anchors WBZ-TV News at 5:30 p.m. Ebben is also an anchor for CBS News Boston and reports across all newscasts including WBZ-TV News' "Eye on Education" ...

Looking for information about the FDA’s limited approval of 2025-26 COVID vaccines? Read what we know about who can get an updated COVID shot this year. Updated Aug. 27 If it feels like several people ...

The trial expects to enrol approximately 210 participants.

A new clinical trial found azelastine cut COVID-19 infections by 70%, hinting at a cheap, accessible way to add protection alongside vaccines. Let’s be honest: when it comes to COVID-19 prevention, ...

New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re like most people in the US, you probably either know someone with COVID-19 right now, know someone who just got over an ...